Cargando…

Nephrotic Syndrome and Statin Therapy: An Outcome Analysis

Background and Objectives: Hypercholesterolemia in patients with nephrotic syndrome (NS) may predispose to cardiovascular events and alter kidney function. We aimed to evaluate statins efficiency in NS patients under immunosuppression using four endpoints: remission rate (RR), end-stage kidney disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Busuioc, Ruxandra, Ștefan, Gabriel, Stancu, Simona, Zugravu, Adrian, Mircescu, Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054350/ https://www.ncbi.nlm.nih.gov/pubmed/36984513 http://dx.doi.org/10.3390/medicina59030512

Ejemplares similares

Histologic predictors of renal outcome in diabetic nephropathy: Beyond renal pathology society classification
por: Stefan, Gabriel, et al.
Publicado: (2019)

Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy
por: Stefan, Gabriel, et al.
Publicado: (2022)

Diffuse calcification of a nonfunctioning kidney allograft
por: Ștefan, Gabriel, et al.
Publicado: (2021)

Multiple Myeloma and Kidney Impairment at Diagnosis: A Nephrological Perspective from an Eastern European Country
por: Ștefan, Gabriel, et al.
Publicado: (2023)

“Associated” or “Secondary” IgA nephropathy? An outcome analysis
por: Obrișcă, Bogdan, et al.
Publicado: (2019)

ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study
por: Andreiana, Iuliana, et al.
Publicado: (2015)

Intrarenal resistive index conundrum: systemic atherosclerosis versus renal arteriolosclerosis
por: Ștefan, Gabriel, et al.
Publicado: (2019)

Clinical features and outcome of maintenance hemodialysis patients with COVID-19 from a tertiary nephrology care center in Romania
por: Stefan, Gabriel, et al.
Publicado: (2020)

Atheroembolic kidney disease: The under‐recognized silent killer
por: Ștefan, Gabriel, et al.
Publicado: (2021)

Subclinical cardiovascular disease markers and vitamin D deficiency in non-dialysis chronic kidney disease patients
por: Căpuşa, Cristina, et al.
Publicado: (2016)

Metabolic acidosis of chronic kidney disease and subclinical cardiovascular disease markers: Friend or foe?
por: Căpuşă, Cristina, et al.
Publicado: (2017)

Predictors of relapses in ANCA-associated small vessel vasculitis with kidney involvement
por: Iuliana, Andreiana, et al.
Publicado: (2014)

Hydroxychloroquine in IgA nephropathy: a systematic review
por: Stefan, Gabriel, et al.
Publicado: (2021)

The safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical study
por: Covic, Adrian, et al.
Publicado: (2010)

Clinical Images: β(2)‐Microglobulin amyloidosis
por: Ștefan, Gabriel, et al.
Publicado: (2021)

Effects of statin therapy and treatment duration on cardiovascular disease risk in patients with nephrotic syndrome: A nested case–control study
por: Zou, Xinliang, et al.
Publicado: (2022)

Nephrotic Syndrome: Genetics, Mechanism, and Therapies
por: Shin, Jae Il, et al.
Publicado: (2018)

Extracorporeal Therapy for Idiopathic Nephrotic Syndrome
por: Au, Eric, et al.
Publicado: (2021)

The Nephrotic Syndrome in Childhood: Prolonged Glucocorticoid Therapy
por: Gryboski, Joyce D., et al.
Publicado: (1962)

Treatment with Statins in Elderly Patients
por: Horodinschi, Ruxandra-Nicoleta, et al.
Publicado: (2019)

Has The Time Arrived to Refine The Indications of Immunosuppressive Therapy and Prognosis in IgA Nephropathy?
por: Obrișcă, Bogdan, et al.
Publicado: (2019)

Genetic analysis and outcomes of Omani children with steroid‐resistant nephrotic syndrome
por: Al Riyami, Mohamed S., et al.
Publicado: (2023)

Studies in the Nephrotic Syndrome
por: Lyon, D. M., et al.
Publicado: (1935)

Complications of nephrotic syndrome
por: Park, Se Jin, et al.
Publicado: (2011)

Cardiovascular Risk and Statin Therapy Considerations in Women
por: Gheorghe, Gina, et al.
Publicado: (2020)

Pulsed Vincristine Therapy in Steroid-Resistant Nephrotic Syndrome
por: Thalgahagoda, Shenal, et al.
Publicado: (2017)

Congenital nephrotic syndrome
por: Jalanko, Hannu
Publicado: (2007)

Long-term Outcomes of Childhood Onset Nephrotic Syndrome
por: Hjorten, Rebecca, et al.
Publicado: (2016)

Adjusting the Lens: Real World Outcomes in Nephrotic Syndrome
por: Castledine, Clare, et al.
Publicado: (2020)

Deep learning analysis of clinical course of primary nephrotic syndrome: Japan Nephrotic Syndrome Cohort Study (JNSCS)
por: Kimura, Tomonori, et al.
Publicado: (2022)

Rituximab therapy in adults with steroid-dependent nephrotic syndrome
por: Zhong, Hongzhen, et al.
Publicado: (2019)

Childhood Nephrotic Syndrome Management and Outcome: A Single Center Retrospective Analysis
por: Wang, Chia-shi, et al.
Publicado: (2017)

Electrospun Fibre Webs Templated Synthesis of Mineral Scaffolds Based on Calcium Phosphates and Barium Titanate
por: Busuioc, Cristina, et al.
Publicado: (2020)

Developing an Edema Clinician-Reported Outcome Measure for Nephrotic Syndrome
por: Gipson, Debbie S., et al.
Publicado: (2023)

The impact of IgM deposits on the outcome of Nephrotic syndrome in children
por: Juozapaite, Sandra, et al.
Publicado: (2017)

Rituximab for nephrotic syndrome in children
por: Iijima, Kazumoto, et al.
Publicado: (2016)

The Role of Cytokines in Nephrotic Syndrome
por: Ahmadian, Elham, et al.
Publicado: (2022)

Analysis of 14 Patients With Congenital Nephrotic Syndrome
por: Chen, Yan, et al.
Publicado: (2019)

Impaired Melatonin Secretion, Oxidative Stress and Metabolic Syndrome in Night Shift Work
por: Hohor, Sorina, et al.
Publicado: (2023)

Targeting Tubulointerstitium to Predict Kidney Outcomes in Childhood Nephrotic Syndrome
por: Azukaitis, Karolis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jdeogoj1vfufk2tianp49jkmrq